$131.33
-2.73-2.04%
At close: May 8, 5:00 PM EST
$131.10
-0.23-0.18%
After Hours: May 8, 5:13 PM EST
Gilead Sciences Inc Stock Guidance
GILDNASDAQ
Earnings: Q1 2026 Earnings were released on Thu May 7th, after the market close
Conference Call: The most recent conference call started at 4:30 PM, 3 days agoClick to view the webcast
Gilead Sciences (GILD) last issued guidance on May 7, 2026 for fiscal year 2026. The company guided earnings per share in the range of $-1.05 - $-0.65, compared to a consensus EPS estimate of $8.65. Gilead Sciences also guided revenue in the range of $30.00B - $30.40B for the period.
Compared to prior guidance, Gilead Sciences lowered its EPS outlook from a previous range of $8.45 - $8.85. On the revenue side, the company raised its revenue forecast from a prior range of $29.60B - $30.00B.
Gilead Sciences has issued 16 guidance updates between August 2, 2022 and May 7, 2026. During this period, the company raised its outlook 8 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
May 7, 2026
Guidance Period
Full Year 2026
EPS Guidance Range
$-1.05 - $-0.65
Revenue Guidance Range
$30.00B - $30.40B
Gilead Sciences Guidance History
Review all historical guidance issued by Gilead Sciences, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Gilead Sciences (GILD)?
The most recent guidance for Gilead Sciences (GILD) was reported on May 7, 2026 for the fiscal year 2026. The company provided earnings per share guidance in the range of $-1.05 to $-0.65, compared to the estimated EPS of $8.65. Additionally, Gilead Sciences forecasted revenue between $30.00B and $30.40B for the period.
What EPS range did Gilead Sciences (GILD) guide for?
Gilead Sciences (GILD) guided EPS in the range of $-1.05 to $-0.65 for the fiscal year 2026. The consensus analyst EPS estimate is $8.65.
What revenue range did Gilead Sciences (GILD) guide for?
Gilead Sciences (GILD) guided revenue in the range of $30.00B to $30.40B for the fiscal year 2026.
Did Gilead Sciences (GILD) raise or lower guidance?
Gilead Sciences (GILD) lowered its EPS guidance from a prior range of $8.45 - $8.85 to $-1.05 - $-0.65 for the fiscal year 2026.
When did Gilead Sciences (GILD) last issue guidance?
Gilead Sciences (GILD) last issued guidance on May 7, 2026 for the fiscal year 2026.
